Hematology/Oncology News

In this episode of Meeting Mic, we continue to bring you pearls and perspectives from the 2024 ASCO Annual Meeting with a focus on leukemia.

During his educational progression from an intern at Stanford University’s ICU to that unit’s senior resident, Tyler Paul Johnson, MD, learned to take an “impenetrable forest of data” and reduce it to its simplest form.

FDA has scaled back its Risk Evaluation and Mitigation Strategy reporting requirements for providers of chimeric antigen receptor T-cell therapies.

Iovance Biotherapeutics has submitted a marketing authorization application to the European Medicines Agency for lifileucel to treat advanced melanoma, the company announced in a press release.

CHICAGO — HPV vaccination rates for children and young adults increased substantially during the 2010s regardless of gender, race or ethnicity, according to findings presented at ASCO Annual Meeting.

Representation of immigrant and Puerto Rican minority medical graduates has increased in the U.S.; however, they continue to experience frequent discrimination, according to study results presented at ASCO Annual Meeting.

Rural populations, especially those with skin of color, experience higher prevalence and an increased risk for skin cancer, according to a study.

To combat the myriad of stressors in life, taking a break to plug into your inner joy opens the door to increased well-being.

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, discusses what she would like to see in the future of myleoproliferate neoplasms care and management.

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, highlights unmet needs in myeloproliferate neoplasms care and management.